111 related articles for article (PubMed ID: 9652981)
1. Effects of OPC-21268, a vasopressin V1-receptor antagonist, on expression of growth factors from glomeruli in spontaneously hypertensive rats.
Otsuka F; Ogura T; Yamauchi T; Oishi T; Hashimoto M; Mimura Y; Makino H
Regul Pept; 1997 Oct; 72(2-3):87-95. PubMed ID: 9652981
[TBL] [Abstract][Full Text] [Related]
2. Effect of continuous infusion of vasopressin on glomerular growth response in spontaneously hypertensive rats.
Harada K; Ogura T; Yamauchi T; Otsuka F; Mimura Y; Hashimoto M; Oishi T; Makino H
Regul Pept; 1998 Apr; 74(1):11-8. PubMed ID: 9657353
[TBL] [Abstract][Full Text] [Related]
3. The angiotensin I-converting enzyme inhibitor, cilazapril inhibits the platelet-derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats.
Yamauchi T; Ogura T; Oishi T; Omiya T; Ota Z
Ren Physiol Biochem; 1995; 18(5):237-45. PubMed ID: 8869081
[TBL] [Abstract][Full Text] [Related]
4. Differential glomerular response to continuous infusion of vasopressin in spontaneously hypertensive rats and Wistar-Kyoto rats.
Kishida M; Otsuka F; Yamauchi T; Ogura T; Takahashi M; Kataoka H; Mimura U; Makino H
Regul Pept; 2000 Feb; 87(1-3):25-32. PubMed ID: 10710285
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
Otsuka F; Yamauchi T; Kataoka H; Mimura Y; Ogura T; Makino H
Am J Physiol; 1998 Jun; 274(6):R1797-806. PubMed ID: 9841488
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a Ca(2+) channel blocker, barnidipine, reduces platelet-derived growth factor B-chain mRNA in glomeruli of spontaneously hypertensive rats.
Hashimoto M; Yamauchi T; Ogura T; Oishi T; Mimura Y; Otsuka F; Kashihara N; Makino H
Am J Nephrol; 1999; 19(5):615-21. PubMed ID: 10575194
[TBL] [Abstract][Full Text] [Related]
7. Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.
Okada H; Suzuki H; Kanno Y; Saruta T
J Cardiovasc Pharmacol; 1995 May; 25(5):847-52. PubMed ID: 7630164
[TBL] [Abstract][Full Text] [Related]
8. Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.
Yamauchi T; Ogura T; Oishi T; Harada K; Hashimoto M; Mimura Y; Asano N; Ota Z; Kageyama J
Acta Med Okayama; 1995 Feb; 49(1):53-9. PubMed ID: 7762410
[TBL] [Abstract][Full Text] [Related]
9. OPC-21268, a vasopressin V1 antagonist, produces hypotension in spontaneously hypertensive rats.
Yamada Y; Yamamura Y; Chihara T; Onogawa T; Nakamura S; Yamashita T; Mori T; Tominaga M; Yabuuchi Y
Hypertension; 1994 Feb; 23(2):200-4. PubMed ID: 8307629
[TBL] [Abstract][Full Text] [Related]
10. Increased glomerular capillary pressure alters glomerular cytokine expression.
Shankland SJ; Ly H; Thai K; Scholey JW
Circ Res; 1994 Nov; 75(5):844-53. PubMed ID: 7923630
[TBL] [Abstract][Full Text] [Related]
11. Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats.
Oishi T; Ogura T; Yamauchi T; Harada K; Ota Z
Regul Pept; 1996 Apr; 62(2-3):89-95. PubMed ID: 8795070
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures.
Fukuda N; Kubo A; Watanabe Y; Nakayama T; Soma M; Izumi Y; Kanmatsuse K
J Hypertens; 1997 Oct; 15(10):1123-36. PubMed ID: 9350586
[TBL] [Abstract][Full Text] [Related]
13. Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis.
Nakamura T; Ebihara I; Fukui M; Osada S; Nagaoka I; Horikoshi S; Tomino Y; Koide H
Clin Immunol Immunopathol; 1993 Jan; 66(1):33-42. PubMed ID: 8095004
[TBL] [Abstract][Full Text] [Related]
14. Effects of vasopressin V1 and V2 receptor antagonists on the development of salt-induced hypertension in Dahl rats.
Hashimoto J; Imai Y; Minami N; Munakata M; Abe K
J Cardiovasc Pharmacol; 1995 Oct; 26(4):548-54. PubMed ID: 8569214
[TBL] [Abstract][Full Text] [Related]
15. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli.
Nakamura T; Ebihara I; Fukui M; Tomino Y; Koide H
Diabetes; 1995 Aug; 44(8):895-9. PubMed ID: 7621993
[TBL] [Abstract][Full Text] [Related]
16. Effect of vasopressin V1- and V2-receptor stimulation on blood pressure in DOCA-salt hypertensive rats.
Mimura Y; Ogura T; Yamauchi T; Otsuka F; Oishi T; Harada K; Hashimoto M; Ota Z
Acta Med Okayama; 1995 Aug; 49(4):187-94. PubMed ID: 7502678
[TBL] [Abstract][Full Text] [Related]
17. The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes.
Kawano Y; Matsuoka H; Nishikimi T; Takishita S; Omae T
Am J Hypertens; 1997 Nov; 10(11):1240-4. PubMed ID: 9397242
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Rolls KA; Johnston CI
Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats.
Nishikimi T; Kawano Y; Saito Y; Matsuoka H
J Cardiovasc Pharmacol; 1996 Feb; 27(2):275-82. PubMed ID: 8720428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
